SCHEMBL4779982

SCHEMBL4779982

COC(=O)c1ccc(NC(=S)NC2CCN(c3nncc4ccc(Br)cc34)CC2)cc1.COc1cccc(NC(=S)NC2CCN(c3nncc4ccc(Br)cc34)CC2)c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.44
MAPT P10636 3/20 0.44
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
CYP1A2 P05177 1/20 0.44
CYP2D6 P10635 1/20 0.44
CYP2C9 P11712 1/20 0.44
CYP2C19 P33261 1/20 0.44
KDM4E B2RXH2 1/20 0.41
NPC1 O15118 1/20 0.39
NFKB1 P19838 1/20 0.39
CASP3 P42574 1/20 0.39
RAB9A P51151 1/20 0.39
NFKB2 Q00653 1/20 0.39
RELA Q04206 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
CCNC P24863 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4725020 0.94 MAPT (0.44) ALDH1A1MAPTMEN1KMT2ACYP1A2
SCHEMBL4584112 0.93 MAPT (0.44) ALDH1A1MAPTKMT2ARAB9AMAPK1
SCHEMBL4584003 0.93 MEN1 (0.51) ALDH1A1MAPTMEN1KMT2ACYP1A2
SCHEMBL4582143 0.90 NPC1 (0.45) ALDH1A1MAPTMEN1KMT2ACYP1A2
SCHEMBL4583673 0.87 EGFR (0.48) RAB9ASMN1; SMN2
SCHEMBL4583028 0.86 MEN1 (0.51) ALDH1A1MAPTMEN1KMT2ACYP1A2
SCHEMBL4582547 0.86 MAPT (0.44) ALDH1A1MAPTKMT2ARAB9AMAPK1
SCHEMBL4727782 0.85 RAB9A (0.43) ALDH1A1MAPTKMT2ARAB9AMAPK1
SCHEMBL4726353 0.85 NPC1 (0.40) ALDH1A1MAPTMEN1KMT2ACYP1A2
SCHEMBL4583648 0.84 MAPK14 (0.46) ALDH1A1MAPTMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008028690-A1 1-(HET)ARYL-3-[HETARYL-PIPERIDIN-4-YL]-THIOUREAS AS MODULATORS OF THE EP2 RECEPTOR BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2008-03-13 WO claimed